Long-term cooperation with the team of prof. Iwao Ojima from the USA, who designs and synthesizes the so-called Stony Brook Taxanes (SB-T derivatives), has previously shown that these substances are very effective against a model of resistant ovarian cancer (Šeborová et al. 2022, doi: 10.3389/fphar.2022.971905). In the work now published, very promising results were also reported for pancreatic cancer, which represents one of the least researched malignancies with a very poor clinical prognosis. Colleagues from FN Královské Vinohrady, SZU, 3LF UK, and the Biotechnology Institute of the Academy of Sciences of the Czech Republic participated in this multidisciplinary work. Intensive study of the mechanisms responsible for the observed effects and work on patient avatars, which is the next preclinical phase of research, is now underway in the laboratories.

Link to the article: https://doi.org/10.1016/j.isci.2024.109044